Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
1.6%
1w
8.4%
1m
13.4%
3m
2.1%
6m
12.0%
1y
7.0%
all
8.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 808 1.6%
767
977
Company Overview

Sales
2,002 Cr
Growth: 15.7%
Profit after Tax
575 Cr
Growth: -2.7%
Large Cap
45,561 Cr
P/E: 79.7x
Industry P/E: 32.5x
Fundamentals

Sales (Cr) ₹ 2,002
Growth 15.7%
EBITDA 39.6%
P/S 22.8x
Dividend 0.0%
P/E 79.7x
Book Value ₹ 56.1
PEG Ratio 5.1x
ROE 19.6%
P/B 14.4x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Investors (1)
Followers (1)